Publications by authors named "Oliver Schofield"

Claim this Profile
L
Long-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrőm macroglobulinaemia.
Ruth de Tute, Nicholas Counsell, Laura Clifton-Hadley, Shirley D'Sa, Guy Pratt, Oliver Schofield

Leukemia· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy with CD25/CD71-allodepleted T cells to improve T-cell reconstitution after matched unrelated donor hematopoietic stem cell transplant: a randomized trial.
Karl S Peggs, Sarah J Albon, Macarena Oporto Espuelas, Catherine Irving, Rachel Richardson, Oliver Schofield

Cytotherapy· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial.
Peter Hoskin, Biliana Popova, Oliver Schofield, Caroline Brammer, Martin Robinson

Lancet Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib consolidation post-ASCT as frontline therapy for multiple myeloma deepens disease response and MRD-negative rate whilst maintaining QOL and response to re-treatment at relapse.
Oliver C Cohen, Nicholas Counsell, Neil Rabin, Rakesh Popat, Roger G Owen, Oliver Schofield

Br J Haematol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis